Fig. 3
From: Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
The distribution of short-term diverse post-COVID-19 vaccine (mostly Sinopharm) side effects related to each type of DMT in 45 women with MS.
Fig. 3 | BMC Immunology